Show simple item record

Angiotensin-converting enzyme inhibitors can be a risk factor for lung cancer!!

dc.contributor.authorAltalhe, Heba Abdalnasser Azouz
dc.date.accessioned2019-06-25T09:09:41Z
dc.date.available2019-06-25T09:09:41Z
dc.date.issued2019-04-09
dc.identifier.urihttp://repository.limu.edu.ly/handle/123456789/991
dc.descriptionAngiotensin converting enzyme inhibitors (ACE inhibitors) are medications that inhibit the activity of the enzyme ACE, which decreases the production of angiotensin II. As a result, blood vessels dilate, and blood pressure is reduced ,the are effective drugs used in the treatment of hypertension[1]. Although these drugs have been shown to be relatively safe in the short term, concerns have been raised that their long term use may be associated with an increased risk of cancer. [2],The Some biological evidence exists for a possible association between ACEIs and risk of lung cancer.en_US
dc.language.isoenen_US
dc.publisherfaculty of Basic Medical Science - Libyan International Medical Universityen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.titleAngiotensin-converting enzyme inhibitors can be a risk factor for lung cancer!!en_US
dc.typeOtheren_US


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution 3.0 United States
Except where otherwise noted, this item's license is described as Attribution 3.0 United States